{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:55:44Z","timestamp":1784303744549,"version":"3.55.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01763-3","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T22:02:55Z","timestamp":1750802575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Microvesicle inhibition enhances the therapeutic effects of ATRA in acute promyelocytic leukemia cells via changes in miRNAs: the promising antileukemic potential of imipramine"],"prefix":"10.1007","volume":"25","author":[{"given":"Haniyeh","family":"Kariminejad-Farsangi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roohollah","family":"Mirzaee Khalilabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Afgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Mirzaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar","family":"Mardani Valandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"issue":"6","key":"1763_CR1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41408-021-00514-3","volume":"11","author":"M Yilmaz","year":"2021","unstructured":"Yilmaz M, Kantarjian H, Ravandi F. Acute promyelocytic leukemia current treatment algorithms. Blood Cancer J. 2021;11(6):123.","journal-title":"Blood Cancer J"},{"issue":"20","key":"1763_CR2","first-page":"2391","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood, J Am Soc Hematol. 2016;127(20):2391\u2013405.","journal-title":"Blood, J Am Soc Hematol"},{"issue":"12","key":"1763_CR3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41408-021-00584-3","volume":"11","author":"RJ Stubbins","year":"2021","unstructured":"Stubbins RJ, Karsan A. Differentiation therapy for myeloid malignancies: beyond cytotoxicity. Blood Cancer J. 2021;11(12):193.","journal-title":"Blood Cancer J"},{"key":"1763_CR4","doi-asserted-by":"crossref","first-page":"1062524","DOI":"10.3389\/fonc.2022.1062524","volume":"12","author":"SG Iyer","year":"2023","unstructured":"Iyer SG, Elias L, Stanchina M, Watts J. The treatment of acute promyelocytic leukemia in 2023: paradigm, advances, and future directions. Front Oncol. 2023;12:1062524.","journal-title":"Front Oncol"},{"issue":"14","key":"1763_CR5","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.3390\/cancers15143637","volume":"15","author":"S Kayser","year":"2023","unstructured":"Kayser S, Conneely SE. Management of acute promyelocytic leukemia at extremes of age. Cancers (Basel). 2023;15(14):3637.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"1763_CR6","first-page":"1875","volume":"113","author":"MA Sanz","year":"2009","unstructured":"Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, J Am Soc Hematol. 2009;113(9):1875\u201391.","journal-title":"Blood, J Am Soc Hematol"},{"issue":"10","key":"1763_CR7","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7150\/ijms.12429","volume":"12","author":"L Li","year":"2015","unstructured":"Li L, Song H, Zhong L, Yang R, Yang X-Q, Jiang K-L, et al. Lithium chloride promotes apoptosis in human leukemia NB4 cells by inhibiting glycogen synthase kinase-3 beta. Int J Med Sci. 2015;12(10):805.","journal-title":"Int J Med Sci"},{"key":"1763_CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.biopha.2018.01.109","volume":"99","author":"S Hassani","year":"2018","unstructured":"Hassani S, Ghaffari P, Chahardouli B, Alimoghaddam K, Ghavamzadeh A, Alizadeh S, et al. Disulfiram\/copper causes ROS levels alteration, cell cycle inhibition, and apoptosis in acute myeloid leukaemia cell lines with modulation in the expression of related genes. Biomed Pharmacother. 2018;99:561\u20139.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1763_CR9","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1172\/JCI81135","volume":"126","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of exosomes in cancer. J Clin Invest. 2016;126(4):1208\u201315.","journal-title":"J Clin Invest"},{"issue":"5","key":"1763_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41590-021-00899-0","volume":"22","author":"C Marar","year":"2021","unstructured":"Marar C, Starich B, Wirtz D. Extracellular vesicles in immunomodulation and tumor progression. Nat Immunol. 2021;22(5):560\u201370. https:\/\/doi.org\/10.1038\/s41590-021-00899-0.","journal-title":"Nat Immunol"},{"issue":"8","key":"1763_CR11","doi-asserted-by":"crossref","first-page":"629874","DOI":"10.3389\/fmolb.2021.629874","volume":"24","author":"R Hayatudin","year":"2021","unstructured":"Hayatudin R, Fong Z, Ming LC, Goh BH, Lee WL, Kifli N. Overcoming chemoresistance via extracellular vesicle inhibition. Front Mol Biosci. 2021;24(8):629874.","journal-title":"Front Mol Biosci."},{"issue":"4","key":"1763_CR12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G Van Niel","year":"2018","unstructured":"Van Niel G, d\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nature Rev Mol Cell Biol. 2018;19(4):213\u201328.","journal-title":"Nature Rev Mol Cell Biol."},{"issue":"5","key":"1763_CR13","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ymthe.2023.02.013","volume":"31","author":"J R\u00e4dler","year":"2023","unstructured":"R\u00e4dler J, Gupta D, Zickler A, Andaloussi SE. Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading. Mol Therapy. 2023;31(5):1231\u201350.","journal-title":"Mol Therapy."},{"key":"1763_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/biom8030094","author":"H Pollet","year":"2018","unstructured":"Pollet H, Conrard L, Cloos A-S, Tyteca D. Plasma membrane lipid domains as platforms for vesicle biogenesis and shedding? Biomolecules. 2018. https:\/\/doi.org\/10.3390\/biom8030094.","journal-title":"Biomolecules"},{"issue":"1","key":"1763_CR15","doi-asserted-by":"crossref","first-page":"1703244","DOI":"10.1080\/20013078.2019.1703244","volume":"9","author":"M Catalano","year":"2020","unstructured":"Catalano M, O\u2019Driscoll L. Inhibiting extracellular vesicles formation and release: a review of EV inhibitors. J Extracellular Vesicles. 2020;9(1):1703244.","journal-title":"J Extracellular Vesicles."},{"key":"1763_CR16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10571-016-0366-z","volume":"36","author":"ER Abels","year":"2016","unstructured":"Abels ER, Breakefield XO. Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake. Cellular Mol Neurobiol. 2016;36:301\u201312.","journal-title":"Cellular Mol Neurobiol."},{"issue":"12","key":"1763_CR17","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1038\/s41375-020-01041-z","volume":"34","author":"MZ Ratajczak","year":"2020","unstructured":"Ratajczak MZ, Ratajczak J. Extracellular microvesicles\/exosomes: discovery, disbelief, acceptance, and the future? Leukemia. 2020;34(12):3126\u201335.","journal-title":"Leukemia"},{"key":"1763_CR18","doi-asserted-by":"crossref","first-page":"692654","DOI":"10.3389\/fimmu.2021.692654","volume":"12","author":"S Hekmatirad","year":"2021","unstructured":"Hekmatirad S, Moloudizargari M, Moghadamnia AA, Kazemi S, Mohammadnia-Afrouzi M, Baeeri M, et al. Inhibition of exosome release sensitizes U937 cells to PEGylated liposomal doxorubicin. Front Immunol. 2021;12:692654.","journal-title":"Front Immunol"},{"key":"1763_CR19","doi-asserted-by":"crossref","unstructured":"Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer. Dis Model Mech. 2021;14(4):dmm047662.","DOI":"10.1242\/dmm.047662"},{"key":"1763_CR20","first-page":"388354","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:388354.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1763_CR21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"issue":"6","key":"1763_CR22","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1002\/jcp.27776","volume":"234","author":"R Mardani","year":"2019","unstructured":"Mardani R, Jafari Najaf Abadi MH, Motieian M, Taghizadeh-Boroujeni S, Bayat A, Farsinezhad A, et al. MicroRNA in leukemia: tumor suppressors and oncogenes with prognostic potential. J Cell Physiol. 2019;234(6):8465\u201386.","journal-title":"J Cell Physiol"},{"key":"1763_CR23","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2147\/CMAR.S238470","volume":"12","author":"S Mansouri","year":"2020","unstructured":"Mansouri S, Khansarinejad B, Mosayebi G, Eghbali A, Mondanizadeh M. Alteration in expression of miR-32 and FBXW7 tumor suppressor in plasma samples of patients with T-cell acute lymphoblastic leukemia. Cancer Manag Res. 2020;12:1253\u20139.","journal-title":"Cancer Manag Res"},{"key":"1763_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020460","author":"S Trino","year":"2018","unstructured":"Trino S, Lamorte D, Caivano A, Laurenzana I, Tagliaferri D, Falco G, et al. MicroRNAs as new biomarkers for diagnosis and prognosis, and as potential therapeutic targets in acute myeloid leukemia. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19020460.","journal-title":"Int J Mol Sci"},{"key":"1763_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020496","author":"S Hatzl","year":"2020","unstructured":"Hatzl S, Perfler B, Wurm S, Uhl B, Quehenberger F, Ebner S, et al. Increased expression of Micro-RNA-23a mediates chemoresistance to cytarabine in acute myeloid leukemia. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12020496.","journal-title":"Cancers (Basel)"},{"issue":"25","key":"1763_CR26","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1038\/onc.2014.274","volume":"34","author":"R Su","year":"2015","unstructured":"Su R, Lin H-S, Zhang X-H, Yin X-L, Ning H-M, Liu B, et al. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets. Oncogene. 2015;34(25):3226\u201339.","journal-title":"Oncogene"},{"issue":"1","key":"1763_CR27","volume":"7","author":"C Hu","year":"2017","unstructured":"Hu C, Yu M, Ren Y, Li K, Maggio DM, Mei C, et al. PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation. Sci Rep. 2017;7(1): 2894.","journal-title":"Sci Rep"},{"issue":"12","key":"1763_CR28","doi-asserted-by":"crossref","first-page":"e83018","DOI":"10.1371\/journal.pone.0083018","volume":"8","author":"I Lepore","year":"2013","unstructured":"Lepore I, Dell\u2019Aversana C, Pilyugin M, Conte M, Nebbioso A, De Bellis F, et al. HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and\/or b. PLoS ONE. 2013;8(12):e83018.","journal-title":"PLoS ONE"},{"issue":"1","key":"1763_CR29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3892\/ijo.2014.2390","volume":"45","author":"F Lu","year":"2014","unstructured":"Lu F, Zhang J, Ji M, Li P, Du Y, Wang H, et al. Mir-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1. Int J Oncol. 2014;45(1):383\u201392.","journal-title":"Int J Oncol"},{"issue":"3","key":"1763_CR30","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.3892\/mmr.2017.7029","volume":"16","author":"T Zhao","year":"2017","unstructured":"Zhao T, Jia H, Zhang Z, Zhao X, Zou Y, Zhang W, et al. LncRNA H19 regulates ID2 expression through competitive binding to hsa-miR-19a\/b in acute myelocytic leukemia. Mol Med Rep. 2017;16(3):3687\u201393.","journal-title":"Mol Med Rep"},{"issue":"16","key":"1763_CR31","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1158\/0008-5472.CAN-14-3521","volume":"75","author":"D Br\u00e4uer-Hartmann","year":"2015","unstructured":"Br\u00e4uer-Hartmann D, Hartmann J-U, Wurm AA, Gerloff D, Katzerke C, Verga Falzacappa MV, et al. PML\/RAR\u03b1-regulated miR-181a\/b cluster targets the tumor suppressor RASSF1A in acute promyelocytic leukemia. Cancer Res. 2015;75(16):3411\u201324.","journal-title":"Cancer Res"},{"issue":"10","key":"1763_CR32","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41419-019-1964-8","volume":"10","author":"S Ganesan","year":"2019","unstructured":"Ganesan S, Palani HK, Lakshmanan V, Balasundaram N, Alex AA, David S, et al. Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia. Cell Death Dis. 2019;10(10):736.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1763_CR33","volume":"8","author":"F Zhi","year":"2013","unstructured":"Zhi F, Cao X, Xie X, Wang B, Dong W, Gu W, et al. Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia. PLoS ONE. 2013;8(2): e56718.","journal-title":"PLoS ONE"},{"issue":"5","key":"1763_CR34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. Clusterprofiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"4","key":"1763_CR35","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/bioinformatics\/btu684","volume":"31","author":"G Yu","year":"2014","unstructured":"Yu G, Wang L-G, Yan G-R, He Q-Y. DOSE: an R\/Bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics. 2014;31(4):608\u20139.","journal-title":"Bioinformatics"},{"issue":"10","key":"1763_CR36","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1182\/bloodadvances.2017015479","volume":"2","author":"L Durrieu","year":"2018","unstructured":"Durrieu L, Bharadwaj A, Waisman DM. Analysis of the thrombotic and fibrinolytic activities of tumor cell\u2013derived extracellular vesicles. Blood Adv. 2018;2(10):1054\u201365.","journal-title":"Blood Adv."},{"issue":"5","key":"1763_CR37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18051013","volume":"18","author":"L Deng","year":"2017","unstructured":"Deng L, Peng Y, Jiang Y, Wu Y, Ding Y, Wang Y, et al. Imipramine protects against bone loss by inhibition of osteoblast-derived microvesicles. Int J Mol Sci. 2017;18(5): 1013.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1763_CR38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fvets.2020.00507","volume":"26","author":"A Faridi","year":"2020","unstructured":"Faridi A, Afgar A, Mousavi SM, Nasibi S, Mohammadi MA, Farajli Abbasi M, Fasihi HM. Intestinal expression of miR-130b, miR-410b, and miR-98a in experimental canine echinococcosis by stem-loop RT-qPCR. Front Veterinary Sci. 2020;26(7):507.","journal-title":"Front Veterinary Sci."},{"key":"1763_CR39","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3389\/fimmu.2018.00738","volume":"9","author":"E Willms","year":"2018","unstructured":"Willms E, Caba\u00f1as C, M\u00e4ger I, Wood MJA, Vader P. Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in cancer progression. Front Immunol. 2018;9:738.","journal-title":"Front Immunol"},{"key":"1763_CR40","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215717","volume":"540","author":"S Timilsina","year":"2022","unstructured":"Timilsina S, Rajamanickam S, Rao A, Subbarayalu P, Nirzhor S, Abdelfattah N, et al. The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events. Cancer Lett. 2022;540: 215717.","journal-title":"Cancer Lett"},{"issue":"20","key":"1763_CR41","volume":"25","author":"EY Lim","year":"2020","unstructured":"Lim EY, Park J, Kim YT, Kim MJ. Imipramine inhibits migration and invasion in metastatic castration-resistant prostate cancer PC-3 cells via AKT-mediated NF-\u03baB signaling pathway. Molecules. 2020;25(20): 4619.","journal-title":"Molecules"},{"key":"1763_CR42","volume":"11","author":"P-F Yueh","year":"2021","unstructured":"Yueh P-F, Lee Y-H, Chiang I-T, Chen W-T, Lan K-L, Chen C-H, et al. Suppression of EGFR\/PKC-\u03b4\/NF-\u03baB signaling associated with imipramine-inhibited progression of non-small cell lung cancer. Front Oncol. 2021;11: 735183.","journal-title":"Front Oncol"},{"issue":"7","key":"1763_CR43","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1111\/jcmm.15022","volume":"24","author":"F-T Hsu","year":"2020","unstructured":"Hsu F-T, Chiang I, Wang W. Induction of apoptosis through extrinsic\/intrinsic pathways and suppression of ERK\/NF-\u03baB signalling participate in anti-glioblastoma of imipramine. J Cell Mol Med. 2020;24(7):3982\u20134000.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"1763_CR44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18051007","volume":"18","author":"US Kosgodage","year":"2017","unstructured":"Kosgodage US, Trindade RP, Thompson PR, Inal JM, Lange S. Chloramidine\/bisindolylmaleimide-I-mediated inhibition of exosome and microvesicle release and enhanced efficacy of cancer chemotherapy. Int J Mol Sci. 2017;18(5): 1007.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1763_CR45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121912","volume":"10","author":"E Chendamarai","year":"2015","unstructured":"Chendamarai E, Ganesan S, Alex AA, Kamath V, Nair SC, Nellickal AJ, et al. Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance. PLoS ONE. 2015;10(3): e0121912.","journal-title":"PLoS ONE"},{"issue":"4","key":"1763_CR46","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.apsb.2021.10.020","volume":"12","author":"X Shao","year":"2022","unstructured":"Shao X, Chen Y, Wang W, Du W, Zhang X, Cai M, et al. Blockade of deubiquitinase YOD1 degrades oncogenic PML\/RAR\u03b1 and eradicates acute promyelocytic leukemia cells. Acta Pharm Sin B. 2022;12(4):1856\u201370.","journal-title":"Acta Pharm Sin B"},{"key":"1763_CR47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fonc.2020.00090","volume":"10","author":"J Nehrbas","year":"2020","unstructured":"Nehrbas J, Butler JT, Chen D-W, Kurre P. Extracellular vesicles and chemotherapy resistance in the AML microenvironment. Front Oncol. 2020;10:90.","journal-title":"Front Oncol"},{"issue":"7","key":"1763_CR48","doi-asserted-by":"crossref","first-page":"100920","DOI":"10.1016\/j.jpha.2023.12.010","volume":"14","author":"H-Y Cheng","year":"2024","unstructured":"Cheng H-Y, Su G-L, Wu Y-X, Chen G, Yu Z-L. Extracellular vesicles in anti-tumor drug resistance: mechanisms and therapeutic prospects. J Pharm Anal. 2024;14(7):100920.","journal-title":"J Pharm Anal"},{"key":"1763_CR49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcdb.2015.02.010","volume":"40","author":"VR Minciacchi","year":"2015","unstructured":"Minciacchi VR, Freeman MR, Di Vizio D. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol. 2015;40:41\u201351.","journal-title":"Semin Cell Dev Biol"},{"issue":"5","key":"1763_CR50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051723","volume":"21","author":"Z Ali Syeda","year":"2020","unstructured":"Ali Syeda Z, Langden SSS, Munkhzul C, Lee M, Song SJ. Regulatory mechanism of MicroRNA expression in cancer. Int J Mol Sci. 2020;21(5): 1723.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1763_CR51","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3892\/ol.2022.13450","volume":"24","author":"H Lu","year":"2022","unstructured":"Lu H, Ding Y, Dong Y, Luo X, Wang X, Xiu B, et al. Microrna-181b-5p insufficiency predicts treatment response failure risk and unfavorable event-free survival as well as overall survival in acute myeloid leukemia patients. Oncol Lett. 2022;24(4):330.","journal-title":"Oncol Lett"},{"issue":"12","key":"1763_CR52","doi-asserted-by":"crossref","first-page":"e996475","DOI":"10.1080\/2162402X.2014.996475","volume":"4","author":"A Nanbakhsh","year":"2015","unstructured":"Nanbakhsh A, Visentin G, Olive D, Janji B, Mussard E, Dessen P, et al. miR-181a modulates acute myeloid leukemia susceptibility to natural killer cells. Oncoimmunology. 2015;4(12):e996475.","journal-title":"Oncoimmunology"},{"issue":"2","key":"1763_CR53","doi-asserted-by":"crossref","first-page":"11898","DOI":"10.1080\/21655979.2021.1999552","volume":"12","author":"H Tian","year":"2021","unstructured":"Tian H, Qiang T, Wang J, Ji L, Li B. Simvastatin regulates the proliferation, apoptosis, migration and invasion of human acute myeloid leukemia cells via miR-19a-3p\/HIF-1\u03b1 axis. Bioengineered. 2021;12(2):11898\u2013908.","journal-title":"Bioengineered"},{"issue":"5","key":"1763_CR54","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1002\/jcp.27393","volume":"234","author":"C Zhao","year":"2019","unstructured":"Zhao C, Wang S, Zhao Y, Du F, Wang W, Lv P, et al. Long noncoding RNA NEAT1 modulates cell proliferation and apoptosis by regulating miR-23a-3p\/SMC1A in acute myeloid leukemia. J Cell Physiol. 2019;234(5):6161\u201372.","journal-title":"J Cell Physiol"},{"issue":"4","key":"1763_CR55","doi-asserted-by":"crossref","first-page":"8881","DOI":"10.1080\/21655979.2022.2056322","volume":"13","author":"X Zhu","year":"2022","unstructured":"Zhu X, Zhang J, Sun Y, Wang Y, Liu Q, Li P, et al. Restoration of miR-23a expression by chidamide sensitizes CML cells to imatinib treatment with concomitant downregulation of CRYAB. Bioengineered. 2022;13(4):8881\u201392.","journal-title":"Bioengineered"},{"issue":"3","key":"1763_CR56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/10409238.2018.1447542","volume":"53","author":"CL Smillie","year":"2018","unstructured":"Smillie CL, Sirey T, Ponting CP. Complexities of post-transcriptional regulation and the modeling of ceRNA crosstalk. Crit Rev Biochem Mol Biol. 2018;53(3):231\u201345.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"8","key":"1763_CR57","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner EF, Nebreda \u00c1R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9(8):537\u201349.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1763_CR58","doi-asserted-by":"crossref","first-page":"945","DOI":"10.7150\/thno.30516","volume":"9","author":"M Ma","year":"2019","unstructured":"Ma M, Dai J, Tang H, Xu T, Yu S, Si L, et al. Microrna-23a-3p inhibits mucosal melanoma growth and progression through targeting adenylate cyclase 1 and attenuating cAMP and MAPK pathways. Theranostics. 2019;9(4):945\u201360.","journal-title":"Theranostics"},{"key":"1763_CR59","doi-asserted-by":"crossref","first-page":"722205","DOI":"10.3389\/fcell.2021.722205","volume":"9","author":"J Yang","year":"2021","unstructured":"Yang J, Liu M, Hong D, Zeng M, Zhang X. The paradoxical role of cellular senescence in cancer. Front cell Dev Biol. 2021;9:722205.","journal-title":"Front cell Dev Biol"},{"issue":"7501","key":"1763_CR60","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature13193","volume":"509","author":"JM Van Deursen","year":"2014","unstructured":"Van Deursen JM. The role of senescent cells in ageing. Nature. 2014;509(7501):439\u201346.","journal-title":"Nature"},{"key":"1763_CR61","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10522-016-9655-7","volume":"17","author":"A Salminen","year":"2016","unstructured":"Salminen A, Kaarniranta K, Kauppinen A. AMPK and HIF signaling pathways regulate both longevity and cancer growth: the good news and the bad news about survival mechanisms. Biogerontology. 2016;17:655\u201380.","journal-title":"Biogerontology"},{"issue":"6","key":"1763_CR62","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.3892\/or.2015.4287","volume":"34","author":"L Li","year":"2015","unstructured":"Li L, Ye S, Yang M, Yu W, Fan Z, Zhang H, et al. SIRT1 downregulation enhances chemosensitivity and survival of adult T-cell leukemia-lymphoma cells by reducing DNA double-strand repair. Oncol Rep. 2015;34(6):2935\u201342.","journal-title":"Oncol Rep"},{"issue":"7","key":"1763_CR63","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1007\/s00125-012-2539-8","volume":"55","author":"B Zhou","year":"2012","unstructured":"Zhou B, Li C, Qi W, Zhang Y, Zhang F, Wu JX, et al. Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity. Diabetologia. 2012;55(7):2032\u201343. https:\/\/doi.org\/10.1007\/s00125-012-2539-8.","journal-title":"Diabetologia"},{"issue":"1","key":"1763_CR64","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bbrc.2017.09.042","volume":"493","author":"Y Wang","year":"2017","unstructured":"Wang Y, Zhu K, Yu W, Wang H, Liu L, Wu Q, et al. MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1. Biochem Biophys Res Commun. 2017;493(1):227\u201332.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1763_CR65","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1139\/bcb-2018-0126","volume":"97","author":"P Tan","year":"2019","unstructured":"Tan P, Guo Y-H, Zhan J-K, Long L-M, Xu M-L, Ye L, et al. LncRNA-ANRIL inhibits cell senescence of vascular smooth muscle cells by regulating miR-181a\/Sirt1. Biochem Cell Biol. 2019;97(5):571\u201380.","journal-title":"Biochem Cell Biol"},{"issue":"4","key":"1763_CR66","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1002\/jcb.27966","volume":"120","author":"B Lei","year":"2019","unstructured":"Lei B, Huang Y, Zhou Z, Zhao Y, Thapa AJ, Li W, et al. Circular RNA hsa_circ_0076248 promotes oncogenesis of glioma by sponging miR-181a to modulate SIRT1 expression. J Cell Biochem. 2019;120(4):6698\u2013708.","journal-title":"J Cell Biochem"},{"key":"1763_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030755","author":"T Tian","year":"2019","unstructured":"Tian T, Li X, Zhang J. mTOR signaling in cancer and mTOR inhibitors in solid tumor targeting therapy. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20030755.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"1763_CR68","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1097\/SPV.0000000000001034","volume":"27","author":"Y Yin","year":"2021","unstructured":"Yin Y, Qin M, Luan M, Xia Z. miR-19-3p promotes autophagy and apoptosis in pelvic organ prolapse through the AKT\/mTOR\/p70S6K pathway: function of miR-19-3p on vaginal fibroblasts by targeting IGF-1. Female Pelvic Med Reconstr Surg. 2021;27(9):e630\u20138.","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"1","key":"1763_CR69","doi-asserted-by":"crossref","first-page":"100007","DOI":"10.1016\/j.clnves.2025.100007","volume":"1","author":"S Hou","year":"2025","unstructured":"Hou S, Liu J, Zhu Y. Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemia. Cell Investig. 2025;1(1):100007.","journal-title":"Cell Investig."}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01763-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01763-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01763-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:51:38Z","timestamp":1764917498000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01763-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1763"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01763-3","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"This study was approved by Kerman University of Medical Science Ethical & Research Committee (ethical code: IR.KMU.REC.1400.696). The volunteers received detailed information regarding the aims and methodology of study. Those who expressed willingness to participate, donate blood sample, and sign an informed consent were subsequently recruited. All methods were conducted according to relevant guidelines and applicable regulations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"217"}}